(1S,2R,3S)-N-[(6S,13S)-20-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methyl-3-pyrimidin-2-ylcyclopropane-1-carboxamide

C59H77N11O8S — CID 176749381

IUPAC(1S,2R,3S)-N-[(6S,13S)-20-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methyl-3-pyrimidin-2-ylcyclopropane-1-carboxamide
SMILESCO[C@@H](C)c1ncc(N2CCN(C3CC3)CC2)cc1-c1c2c3cc(ccc3n1CCOC1CCOCC1)-c1csc(n1)[C@@H](N1CCOCC1)C(NC(=O)[C@H]1[C@H](C)[C@@H]1c1ncccn1)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2
InChIInChI=1S/C59H77N11O8S/c1-36-48(54-60-15-7-16-61-54)49(36)55(71)64-51-53(68-22-27-76-28-23-68)56-63-46(34-79-56)38-9-12-47-42(30-38)44(32-59(3,4)35-78-58(73)45-8-6-17-70(65-45)57(51)72)52(69(47)24-29-77-41-13-25-75-26-14-41)43-31-40(33-62-50(43)37(2)74-5)67-20-18-66(19-21-67)39-10-11-39/h7,9,12,15-16,30-31,33-34,36-37,39,41,45,48-49,51,53,65H,6,8,10-11,13-14,17-29,32,35H2,1-5H3,(H,64,71)/t36-,37+,45+,48+,49+,51?,53+/m1/s1
InChIKeyUZMDAEAGZCKIPW-FWYVTMCZSA-N
MW1100.40 g/mol
LogP6.33
Rot. Bonds13

About (1S,2R,3S)-N-[(6S,13S)-20-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methyl-3-pyrimidin-2-ylcyclopropane-1-carboxamide

(1S,2R,3S)-N-[(6S,13S)-20-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methyl-3-pyrimidin-2-ylcyclopropane-1-carboxamide (PubChem CID 176749381) has the molecular formula C59H77N11O8S and a molecular weight of 1100.40 g/mol. Its IUPAC name is (1S,2R,3S)-N-[(6S,13S)-20-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methyl-3-pyrimidin-2-ylcyclopropane-1-carboxamide.

Molecular Properties

Compound Name(1S,2R,3S)-N-[(6S,13S)-20-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methyl-3-pyrimidin-2-ylcyclopropane-1-carboxamide
PubChem CID176749381
Molecular FormulaC59H77N11O8S
Molecular Weight1100.40 g/mol
Exact Mass1099.57
IUPAC Name(1S,2R,3S)-N-[(6S,13S)-20-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methyl-3-pyrimidin-2-ylcyclopropane-1-carboxamide
SMILESCO[C@@H](C)c1ncc(N2CCN(C3CC3)CC2)cc1-c1c2c3cc(ccc3n1CCOC1CCOCC1)-c1csc(n1)[C@@H](N1CCOCC1)C(NC(=O)[C@H]1[C@H](C)[C@@H]1c1ncccn1)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2
InChIInChI=1S/C59H77N11O8S/c1-36-48(54-60-15-7-16-61-54)49(36)55(71)64-51-53(68-22-27-76-28-23-68)56-63-46(34-79-56)38-9-12-47-42(30-38)44(32-59(3,4)35-78-58(73)45-8-6-17-70(65-45)57(51)72)52(69(47)24-29-77-41-13-25-75-26-14-41)43-31-40(33-62-50(43)37(2)74-5)67-20-18-66(19-21-67)39-10-11-39/h7,9,12,15-16,30-31,33-34,36-37,39,41,45,48-49,51,53,65H,6,8,10-11,13-14,17-29,32,35H2,1-5H3,(H,64,71)/t36-,37+,45+,48+,49+,51?,53+/m1/s1
InChIKeyUZMDAEAGZCKIPW-FWYVTMCZSA-N
XLogP6.33
TPSA190.87 Ų
H-Bond Donors2
H-Bond Acceptors18
Rotatable Bonds13
Heavy Atoms79
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001100.40
LogP ≤ 56.33
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1018

Analyze (1S,2R,3S)-N-[(6S,13S)-20-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methyl-3-pyrimidin-2-ylcyclopropane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1S,2R,3S)-N-[(6S,13S)-20-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methyl-3-pyrimidin-2-ylcyclopropane-1-carboxamide?
The IUPAC name of (1S,2R,3S)-N-[(6S,13S)-20-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methyl-3-pyrimidin-2-ylcyclopropane-1-carboxamide (CID 176749381) is (1S,2R,3S)-N-[(6S,13S)-20-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methyl-3-pyrimidin-2-ylcyclopropane-1-carboxamide.
What is the SMILES notation for (1S,2R,3S)-N-[(6S,13S)-20-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methyl-3-pyrimidin-2-ylcyclopropane-1-carboxamide?
The canonical SMILES for (1S,2R,3S)-N-[(6S,13S)-20-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methyl-3-pyrimidin-2-ylcyclopropane-1-carboxamide is CO[C@@H](C)c1ncc(N2CCN(C3CC3)CC2)cc1-c1c2c3cc(ccc3n1CCOC1CCOCC1)-c1csc(n1)[C@@H](N1CCOCC1)C(NC(=O)[C@H]1[C@H](C)[C@@H]1c1ncccn1)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2.
What is the InChIKey of (1S,2R,3S)-N-[(6S,13S)-20-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methyl-3-pyrimidin-2-ylcyclopropane-1-carboxamide?
The InChIKey is UZMDAEAGZCKIPW-FWYVTMCZSA-N. The full InChI is InChI=1S/C59H77N11O8S/c1-36-48(54-60-15-7-16-61-54)49(36)55(71)64-51-53(68-22-27-76-28-23-68)56-63-46(34-79-56)38-9-12-47-42(30-38)44(32-59(3,4)35-78-58(73)45-8-6-17-70(65-45)57(51)72)52(69(47)24-29-77-41-13-25-75-26-14-41)43-31-40(33-62-50(43)37(2)74-5)67-20-18-66(19-21-67)39-10-11-39/h7,9,12,15-16,30-31,33-34,36-37,39,41,45,48-49,51,53,65H,6,8,10-11,13-14,17-29,32,35H2,1-5H3,(H,64,71)/t36-,37+,45+,48+,49+,51?,53+/m1/s1.
What are the key properties of (1S,2R,3S)-N-[(6S,13S)-20-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methyl-3-pyrimidin-2-ylcyclopropane-1-carboxamide?
(1S,2R,3S)-N-[(6S,13S)-20-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methyl-3-pyrimidin-2-ylcyclopropane-1-carboxamide has a molecular weight of 1100.40 g/mol, XLogP of 6.33, 13 rotatable bonds, 2 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,2R,3S)-N-[(6S,13S)-20-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-6-morpholin-4-yl-21-[2-(oxan-4-yloxy)ethyl]-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methyl-3-pyrimidin-2-ylcyclopropane-1-carboxamide is sourced from PubChem (CID 176749381), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).